/PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on.
HERZLIYA, Israel and CALGARY, AB, May 27, 2024 /PRNewswire/ Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company
Innocan Pharma Corporation: Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Innocan Pharma Reports Full Year 2023 Results With Revenues Up Nearly 6X To $13.7M menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
HERZLIYA, Israel and CALGARY, Alberta, April 1, 2024 /CNW/ Innocan Pharma Corporation , a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies.